FM Helmerhorst

2.6k total citations
41 papers, 1.9k citations indexed

About

FM Helmerhorst is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, FM Helmerhorst has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Public Health, Environmental and Occupational Health and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in FM Helmerhorst's work include Platelet Disorders and Treatments (10 papers), Reproductive Health and Contraception (8 papers) and Assisted Reproductive Technology and Twin Pregnancy (7 papers). FM Helmerhorst is often cited by papers focused on Platelet Disorders and Treatments (10 papers), Reproductive Health and Contraception (8 papers) and Assisted Reproductive Technology and Twin Pregnancy (7 papers). FM Helmerhorst collaborates with scholars based in Netherlands, United States and Australia. FM Helmerhorst's co-authors include Olaf M. Dekkers, C. P. Engelfriet, Sandra Dieben, J A Romijn, A. E. G. Kr. von dem Borne, K.W.M. Bloemenkamp, Jan P. Vandenbroucke, F.R. Rosendaal, E. F. van Leeuwen and F.R. Rosendaal and has published in prestigious journals such as Cochrane Database of Systematic Reviews, BMJ and The Journal of Urology.

In The Last Decade

FM Helmerhorst

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
FM Helmerhorst Netherlands 24 649 624 596 316 224 41 1.9k
D Yeates United Kingdom 24 112 0.2× 594 1.0× 563 0.9× 219 0.7× 376 1.7× 37 2.2k
H Abramovici Israel 26 116 0.2× 593 1.0× 516 0.9× 453 1.4× 414 1.8× 140 1.9k
Stella Thomassen Netherlands 28 2.2k 3.4× 579 0.9× 144 0.2× 177 0.6× 84 0.4× 65 3.1k
Hidehiko Matsubayashi Japan 22 301 0.5× 386 0.6× 901 1.5× 242 0.8× 425 1.9× 83 1.8k
G. C. M. L. Christiaens Netherlands 25 362 0.6× 331 0.5× 199 0.3× 821 2.6× 353 1.6× 61 1.7k
Élisabeth Éléfant France 21 156 0.2× 1.4k 2.2× 163 0.3× 480 1.5× 356 1.6× 87 2.2k
M Renaer Belgium 13 194 0.3× 241 0.4× 250 0.4× 318 1.0× 460 2.1× 19 1.2k
Joseph A. Spinnato United States 28 312 0.5× 485 0.8× 72 0.1× 796 2.5× 910 4.1× 72 2.1k
Jenny Higham United Kingdom 23 145 0.2× 600 1.0× 1.2k 2.1× 137 0.4× 1.1k 5.0× 50 2.3k
Terry McCarthy Singapore 14 50 0.1× 328 0.5× 121 0.2× 155 0.5× 135 0.6× 41 848

Countries citing papers authored by FM Helmerhorst

Since Specialization
Citations

This map shows the geographic impact of FM Helmerhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FM Helmerhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FM Helmerhorst more than expected).

Fields of papers citing papers by FM Helmerhorst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FM Helmerhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FM Helmerhorst. The network helps show where FM Helmerhorst may publish in the future.

Co-authorship network of co-authors of FM Helmerhorst

This figure shows the co-authorship network connecting the top 25 collaborators of FM Helmerhorst. A scholar is included among the top collaborators of FM Helmerhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FM Helmerhorst. FM Helmerhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timp, J.F., Bernardine H. Stegeman, J.F. Timp, et al.. (2013). Recurrent venous thrombosis in premenopausal women : effect of hormonal contraceptive use. Journal of Thrombosis and Haemostasis. 11. 115–116.
2.
Dekkers, Olaf M., et al.. (2011). PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. 26. 2 indexed citations
3.
Dekkers, Olaf M., et al.. (2011). PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human Reproduction Update. 17(4). 495–500. 309 indexed citations
4.
Knoester, Marjolein, et al.. (2007). Matched follow-up study of 5 8-year-old ICSI singletons: child behaviour, parenting stress and child (health-related) quality of life. Human Reproduction. 22(12). 3098–3107. 61 indexed citations
5.
Kulier, Regina, et al.. (2006). Copper containing, framed intra-uterine devices for contraception. Cochrane Database of Systematic Reviews. CD005347–CD005347. 39 indexed citations
6.
Vliet, Hubertus A.A.M. van, David A. Grimes, Laureen M Lopez, Klaus‐Peter Schulz, & FM Helmerhorst. (2006). Triphasic versus monophasic oral contraceptives for contraception. Cochrane Database of Systematic Reviews. CD003553–CD003553. 51 indexed citations
7.
Brewaeys, Anne, et al.. (2005). Anonymous or identity-registered sperm donors? A study of Dutch recipients' choices. Human Reproduction. 20(3). 820–824. 57 indexed citations
8.
Groot, Christianne J.M. de, Mieke Jansen, Rogier M. Bertina, et al.. (2004). Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes and Immunity. 5(4). 313–314. 37 indexed citations
9.
Grimes, DA, et al.. (2001). Biphasic versus monophasic oral contraceptives for contraception. Cochrane Database of Systematic Reviews. CD002032–CD002032. 6 indexed citations
10.
Bloemenkamp, K.W.M., F.R. Rosendaal, FM Helmerhorst, & Jan P. Vandenbroucke. (2000). Higher Risk of Venous Thrombosis During Early Use of Oral Contraceptives in Women With Inherited Clotting Defects. Archives of Internal Medicine. 160(1). 49–49. 144 indexed citations
11.
Hédon, B., FM Helmerhorst, H. S. Cronjé, et al.. (2000). Comparison of efficacy, cycle control, compliance, and safety in users of a contraceptive patch vs an oral contraceptive. International Journal of Gynecology & Obstetrics. 70(S2). 27 indexed citations
12.
Helmerhorst, FM, Martijn J.J. Finken, & J.J.H.M. Erwich. (1999). Antisperm antibodies. Human Reproduction. 14(7). 1669–1671. 32 indexed citations
13.
Oei, S. Guid, et al.. (1998). Effectiveness of the postcoital test: randomised controlled trial. BMJ. 317(7157). 502–505. 51 indexed citations
14.
Weiden, R.M.F. van der, Lambertus J. Wisse, FM Helmerhorst, Marc J. N. C. Keirse, & R. E. Poelmann. (1996). Immunohistochemical and ultrastructural localization of prostaglandin H synthase in the preimplantation mouse embryo. Reproduction. 107(2). 161–166. 16 indexed citations
15.
Brewaeys, Anne, et al.. (1995). Lesbian mothers who conceived after donor insemination: a follow-up study. Human Reproduction. 10(10). 2731–2735. 32 indexed citations
16.
Borne, A. E. G. Kr. von dem, et al.. (1986). Thrombocytopenia associated with gold therapy: a drug‐induced autoimmune disease?. British Journal of Haematology. 63(3). 509–516. 35 indexed citations
17.
Helmerhorst, FM, et al.. (1982). Primary and Secondary Autoimmune Thrombocytopenia. Scandinavian Journal of Haematology. 28(4). 319–328. 14 indexed citations
18.
Helmerhorst, FM, et al.. (1981). Neutrophil‐specific antigen NE1 is not the antithetical allele of ND1. Tissue Antigens. 18(2). 139–140. 1 indexed citations
19.
Leeuwen, E. F. van, FM Helmerhorst, C. P. Engelfriet, & A E von dem Borne. (1981). Maternal autoimmune thrombocytopenia and the newborn.. BMJ. 283(6284). 104–104. 6 indexed citations
20.
Borne, A. E. G. Kr. von dem, et al.. (1980). Autoimmune Thrombocytopenia: Detection of Platelet Autoantibodies with the Suspension Immunofluorescence Test. British Journal of Haematology. 45(2). 319–327. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026